new oral glp 1 agonist GLP-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and obesity care. Amid the enthusiasm, however, a quieter and clinically important issue is The Ozempic Effect: Navigating GLP-1

Congress exempts compounded medications from FDA approval via Section 503A of the Federal Food, Drug, and Cosmetic Act

The researchers got half of their subjects to apply a solution that consisted of 2 percent L-carnitine-L-tartrate to the skin on their head twice a day

Cancer 19 , 439453 (2019)

Nature , 563, 354 359

Drug Trials Snapshots: DEFENCATH HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups

The vast majority of compounds show a reduced or even complete loss of the therapeutic effect under hypoxic conditions